102 related articles for article (PubMed ID: 30196178)
1. Expression of Cyclin E/Cdk2/p27
Dong W; Zhu H; Gao H; Shi W; Zhang Y; Wang H; Li C; Song G; Zhang Y
World Neurosurg; 2019 Jan; 121():e45-e53. PubMed ID: 30196178
[TBL] [Abstract][Full Text] [Related]
2. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
3. P21
Dong W; Li J; Liu Q; Liu C; Li C; Song G; Zhu H; Gao H; Zhang Y
J Neurooncol; 2018 Feb; 136(3):485-494. PubMed ID: 29230669
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
5. [Effect of weikangning decoction on expression of cyclin E, CDK2, and p27].
Kan FJ; Li QM; Zhong W; Liang WW
Zhong Yao Cai; 2006 Apr; 29(4):341-5. PubMed ID: 16913488
[TBL] [Abstract][Full Text] [Related]
6. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol.
Huang Z; Wang L; Chen L; Zhang Y; Shi P
Acta Pharm; 2015 Dec; 65(4):463-71. PubMed ID: 26677902
[TBL] [Abstract][Full Text] [Related]
8. Bottom-up cell proliferation with cyclin A and p27Kip1 expression in ulcerative colitis-associated dysplasia.
Mikami T; Yoshida T; Shiraishi H; Tokuyama W; Motoori T; Okayasu I
Pathol Int; 2006 Jan; 56(1):10-6. PubMed ID: 16398674
[TBL] [Abstract][Full Text] [Related]
9. Role of Genetic Variations in
Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
[TBL] [Abstract][Full Text] [Related]
10. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
12. Hexachlorobenzene alters cell cycle by regulating p27-cyclin E-CDK2 and c-Src-p27 protein complexes.
Ventura C; Núñez M; Gaido V; Pontillo C; Miret N; Randi A; Cocca C
Toxicol Lett; 2017 Mar; 270():72-79. PubMed ID: 28215542
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
[TBL] [Abstract][Full Text] [Related]
14. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
Chu I; Sun J; Arnaout A; Kahn H; Hanna W; Narod S; Sun P; Tan CK; Hengst L; Slingerland J
Cell; 2007 Jan; 128(2):281-94. PubMed ID: 17254967
[TBL] [Abstract][Full Text] [Related]
15. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
[TBL] [Abstract][Full Text] [Related]
16. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression.
Miyai K; Yamamoto S; Iwaya K; Asano T; Tamai S; Tsuda H; Matsubara O
APMIS; 2012 Nov; 120(11):890-900. PubMed ID: 23009113
[TBL] [Abstract][Full Text] [Related]
18. A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy.
Dai L; Liu Y; Liu J; Wen X; Xu Z; Wang Z; Sun H; Tang S; Maguire AR; Quan J; Zhang H; Ye T
Cancer Lett; 2013 Jun; 333(1):103-12. PubMed ID: 23354589
[TBL] [Abstract][Full Text] [Related]
19. Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.
Flores O; Wang Z; Knudsen KE; Burnstein KL
Endocrinology; 2010 Mar; 151(3):896-908. PubMed ID: 20147522
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
